Balchem Corp
BCPC156.300USD
-2.420-1.52%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
5.06BMarket Cap
33.90P/E TTM
More Details of Balchem Corp Company
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Balchem Corp Info
Ticker SymbolBCPC
Company nameBalchem Corp
IPO dateJun 03, 1986
CEOHarris (Theodore L)
Number of employees1361
Security typeOrdinary Share
Fiscal year-endJun 03
Address- -
City- -
Stock exchangeNASDAQ OMX - NASDAQ BASIC
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolBCPC
IPO dateJun 03, 1986
CEOHarris (Theodore L)
Company Executives of Balchem Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
61.58K
-0.77%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
5.94K
-25.19%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
1.55K
-23.80%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
410.00
-78.03%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Monica Vicente
Ms. Monica Vicente
Independent Director
Independent Director
--
-100.00%
Mr. Olivier Rigaud
Mr. Olivier Rigaud
Independent Director
Independent Director
--
-100.00%
Mr. Daniel E. Knutson, CPA
Mr. Daniel E. Knutson, CPA
Independent Director
Independent Director
--
--
Mr. Martin L. Reid
Mr. Martin L. Reid
Senior Vice President and Chief Supply Chain Officer
Senior Vice President and Chief Supply Chain Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
61.58K
-0.77%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
5.94K
-25.19%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
1.55K
-23.80%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
410.00
-78.03%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Product Sales Revenue
255.04M
99.83%
Royalty
426.00K
0.17%
By RegionUSD
Name
Revenue
Proportion
United States
186.71M
73.08%
Foreign Countries
68.76M
26.92%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product Sales Revenue
255.04M
99.83%
Royalty
426.00K
0.17%
Shareholding Stats
Updated: Wed, Oct 8
Updated: Wed, Oct 8
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.43%
The Vanguard Group, Inc.
12.00%
Conestoga Capital Advisors, LLC
3.93%
State Street Investment Management (US)
3.71%
Wasatch Global Investors Inc
3.34%
Other
63.60%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.43%
The Vanguard Group, Inc.
12.00%
Conestoga Capital Advisors, LLC
3.93%
State Street Investment Management (US)
3.71%
Wasatch Global Investors Inc
3.34%
Other
63.60%
Shareholder Types
Shareholders
Proportion
Investment Advisor
51.15%
Investment Advisor/Hedge Fund
28.69%
Hedge Fund
6.00%
Pension Fund
2.43%
Research Firm
1.95%
Sovereign Wealth Fund
1.59%
Bank and Trust
1.04%
Individual Investor
0.54%
Family Office
0.06%
Other
6.56%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
692
30.08M
92.73%
+17.89K
2025Q3
707
30.06M
92.66%
+267.74K
2025Q2
685
29.78M
92.71%
+58.29K
2025Q1
661
29.74M
93.11%
-556.18K
2024Q4
638
29.76M
94.56%
+6.32K
2024Q3
611
29.83M
94.33%
+196.23K
2024Q2
600
29.66M
94.99%
-187.86K
2024Q1
588
29.84M
94.20%
-559.06K
2023Q4
578
29.57M
93.53%
+265.95K
2023Q3
565
29.33M
93.21%
-102.61K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
4.44M
13.67%
-111.30K
-2.45%
Jun 30, 2025
The Vanguard Group, Inc.
3.89M
11.99%
+47.60K
+1.24%
Jun 30, 2025
Conestoga Capital Advisors, LLC
1.15M
3.54%
-19.03K
-1.63%
Jun 30, 2025
State Street Investment Management (US)
1.23M
3.78%
-1.53K
-0.12%
Jun 30, 2025
Wasatch Global Investors Inc
960.09K
2.96%
-108.92K
-10.19%
Jun 30, 2025
Geode Capital Management, L.L.C.
980.97K
3.02%
+14.33K
+1.48%
Jun 30, 2025
Geneva Capital Management LLC
895.53K
2.76%
+64.72K
+7.79%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
575.40K
1.77%
-18.35K
-3.09%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
469.08K
1.45%
+38.60K
+8.97%
Jun 30, 2025
JP Morgan Asset Management
389.05K
1.2%
-7.19K
-1.82%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco S&P SmallCap Materials ETF
6.89%
Invesco S&P SmallCap Quality ETF
1.2%
First Trust Horizon Managed Vol Small/Mid ETF
1.05%
ProShares Russell 2000 Dividend Growers ETF
0.91%
Invesco S&P SmallCap Low Volatility ETF
0.87%
State Street SPDR S&P 600 Small Cap Growth ETF
0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.64%
iShares S&P Small-Cap 600 Growth ETF
0.63%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.57%
Parametric Equity Premium Income ETF
0.56%
View more
Invesco S&P SmallCap Materials ETF
Proportion6.89%
Invesco S&P SmallCap Quality ETF
Proportion1.2%
First Trust Horizon Managed Vol Small/Mid ETF
Proportion1.05%
ProShares Russell 2000 Dividend Growers ETF
Proportion0.91%
Invesco S&P SmallCap Low Volatility ETF
Proportion0.87%
State Street SPDR S&P 600 Small Cap Growth ETF
Proportion0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proportion0.64%
iShares S&P Small-Cap 600 Growth ETF
Proportion0.63%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proportion0.57%
Parametric Equity Premium Income ETF
Proportion0.56%
Dividend
A total of
104.59M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Dec 10, 2025
BCPC.NB Final Cash Dividend of gross USD 0.96 paid on Jan 20, 2026 going ex on Dec 23, 2025
Dec 23, 2025
Jan 20, 2026
Dec 23, 2025
Dec 10, 2024
BCPC.NB Final Cash Dividend of gross USD 0.87 paid on Jan 17, 2025 going ex on Dec 26, 2024
Dec 26, 2024
Jan 17, 2025
Dec 26, 2024
Dec 05, 2023
BCPC.NB Final Cash Dividend of gross USD 0.79 paid on Jan 19, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 19, 2024
Dec 26, 2023
Dec 06, 2022
BCPC.NB Final Cash Dividend of gross USD 0.71 paid on Jan 20, 2023 going ex on Dec 23, 2022
Dec 27, 2022
Jan 20, 2023
Dec 23, 2022
Dec 16, 2021
BCPC.NB Final Cash Dividend of gross USD 0.64 paid on Jan 21, 2022 going ex on Dec 27, 2021
Dec 28, 2021
Jan 21, 2022
Dec 27, 2021
Dec 17, 2020
BCPC.NB Final Cash Dividend of gross USD 0.58 paid on Jan 22, 2021 going ex on Dec 24, 2020
Dec 28, 2020
Jan 22, 2021
Dec 24, 2020
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Balchem Corp?
The top five shareholders of Balchem Corp are:
BlackRock Institutional Trust Company, N.A. holds 4.44M shares, accounting for 13.67% of the total shares.
The Vanguard Group, Inc. holds 3.89M shares, accounting for 11.99% of the total shares.
Conestoga Capital Advisors, LLC holds 1.15M shares, accounting for 3.54% of the total shares.
State Street Investment Management (US) holds 1.23M shares, accounting for 3.78% of the total shares.
Wasatch Global Investors Inc holds 960.09K shares, accounting for 2.96% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 4.44M shares, accounting for 13.67% of the total shares.
The Vanguard Group, Inc. holds 3.89M shares, accounting for 11.99% of the total shares.
Conestoga Capital Advisors, LLC holds 1.15M shares, accounting for 3.54% of the total shares.
State Street Investment Management (US) holds 1.23M shares, accounting for 3.78% of the total shares.
Wasatch Global Investors Inc holds 960.09K shares, accounting for 2.96% of the total shares.
What are the top three shareholder types of Balchem Corp?
The top three shareholder types of Balchem Corp are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC
How many institutions hold shares of Balchem Corp (BCPC)?
As of 2025Q4, 692 institutions hold shares of Balchem Corp, with a combined market value of approximately 30.08M, accounting for 92.73% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 0.07%.
What is the biggest source of revenue for Balchem Corp?
In FY2025Q2, the Product Sales Revenue business generated the highest revenue for Balchem Corp, amounting to 255.04M and accounting for 99.83% of total revenue.
